Skip to main content
logo
Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.45
+0.07 (1.30%)
At close: Jul 20, 2026, 4:00 PM EDT
5.46
+0.01 (0.20%)
Pre-market: Jul 21, 2026, 5:00 AM EDT

Unicycive Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.680.95-
Revenue Growth (YoY)
----29.02%--
Gross Profit
---0.680.95-
Selling, General & Admin
21.420.412.18.556.572.9
Research & Development
8.579.1220.0112.912.446.08
Total Operating Expenses
29.9729.5232.1221.45198.98
Operating Income
-29.97-29.52-32.12-20.77-18.05-8.98
Interest Income
1.181.011.260.62--
Interest Expense
-0.06-0.07-0.07-0.08-0.01-0.63
Other Non-Operating Income (Expense)
-11.112.02-5.8-10.3--0.41
Total Non-Operating Income (Expense)
-9.982.96-4.61-9.77-0.01-1.04
Pretax Income
-39.95-26.56-36.73-30.54-18.06-10.02
Net Income
-39.95-26.56-36.73-30.54-18.06-10.02
Net Income Attributable to Preferred Dividends
--1.10.87--
Net Income to Common
-39.95-26.56-37.82-31.41-18.06-10.02
Shares Outstanding (Basic)
4,531167221
Shares Outstanding (Diluted)
4,531167221
Shares Change (YoY)
103.02%137.17%172.97%62.98%28.96%37.37%
EPS (Basic)
-2.21-1.67-5.65-12.80-12.00-8.60
EPS (Diluted)
-2.21-1.67-5.65-12.80-12.00-8.60
Free Cash Flow
-28.67-31.34-28.65-18.3-15.65-5.8
Free Cash Flow Per Share
-0.01-1.97-4.28-7.46-10.40-4.96
Gross Margin
---100.00%100.00%-
Operating Margin
----3077.63%-1898.21%-
Profit Margin
----4525.04%-1898.84%-
FCF Margin
----2710.37%-1645.95%-
EBITDA
-29.32-28.95-31.69-20.49-17.89-8.96
EBITDA Margin
----3035.56%-1881.28%-
EBIT
-29.97-29.52-32.12-20.77-18.05-8.98
EBIT Margin
----3077.63%-1898.21%-
SEC Filings: 10-K · 10-Q